222 related articles for article (PubMed ID: 23376149)
1. Methylation of the RARB gene increases prostate cancer risk in black Americans.
Tang D; Kryvenko ON; Mitrache N; Do KC; Jankowski M; Chitale DA; Trudeau S; Rundle A; Belinsky SA; Rybicki BA
J Urol; 2013 Jul; 190(1):317-24. PubMed ID: 23376149
[TBL] [Abstract][Full Text] [Related]
2. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
[TBL] [Abstract][Full Text] [Related]
3. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
[TBL] [Abstract][Full Text] [Related]
4. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
Singal R; Ferdinand L; Reis IM; Schlesselman JJ
Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
[TBL] [Abstract][Full Text] [Related]
5. Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer.
Rybicki BA; Rundle A; Kryvenko ON; Mitrache N; Do KC; Jankowski M; Chitale DA; Trudeau S; Belinsky SA; Tang D
Int J Cancer; 2016 Jun; 138(12):2884-93. PubMed ID: 26860439
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.
Singal R; Das PM; Manoharan M; Reis IM; Schlesselman JJ
Oncol Rep; 2005 Aug; 14(2):569-73. PubMed ID: 16012746
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
Kwabi-Addo B; Wang S; Chung W; Jelinek J; Patierno SR; Wang BD; Andrawis R; Lee NH; Apprey V; Issa JP; Ittmann M
Clin Cancer Res; 2010 Jul; 16(14):3539-47. PubMed ID: 20606036
[TBL] [Abstract][Full Text] [Related]
8. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.
Oakley-Girvan I; Feldman D; Eccleshall TR; Gallagher RP; Wu AH; Kolonel LN; Halpern J; Balise RR; West DW; Paffenbarger RS; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1325-30. PubMed ID: 15298953
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of DNA methylation in multifocal prostate cancer.
Serenaite I; Daniunaite K; Jankevicius F; Laurinavicius A; Petroska D; Lazutka JR; Jarmalaite S
Virchows Arch; 2015 Jan; 466(1):53-9. PubMed ID: 25369892
[TBL] [Abstract][Full Text] [Related]
10. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
[TBL] [Abstract][Full Text] [Related]
11. DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer.
Litovkin K; Van Eynde A; Joniau S; Lerut E; Laenen A; Gevaert T; Gevaert O; Spahn M; Kneitz B; Gramme P; Helleputte T; Isebaert S; Haustermans K; Bollen M
PLoS One; 2015; 10(6):e0130651. PubMed ID: 26086362
[TBL] [Abstract][Full Text] [Related]
12. Gene promoter methylation and cancer: An umbrella review.
Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.
Rowland GW; Schwartz GG; John EM; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):16-24. PubMed ID: 23129590
[TBL] [Abstract][Full Text] [Related]
14. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Pookot D; Li LC; Tabatabai ZL; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Int J Cancer; 2005 Aug; 116(2):174-81. PubMed ID: 15800905
[TBL] [Abstract][Full Text] [Related]
15. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
17. Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity.
Apprey V; Wang S; Tang W; Kittles RA; Southerland WM; Ittmann M; Kwabi-Addo B
Anticancer Res; 2019 Nov; 39(11):5861-5866. PubMed ID: 31704810
[TBL] [Abstract][Full Text] [Related]
18. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
19. Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.
Tang D; Kryvenko ON; Wang Y; Jankowski M; Trudeau S; Rundle A; Rybicki BA
Carcinogenesis; 2013 Jan; 34(1):113-20. PubMed ID: 23066084
[TBL] [Abstract][Full Text] [Related]
20. Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men.
Moses-Fynn E; Tang W; Beyene D; Apprey V; Copeland R; Kanaan Y; Kwabi-Addo B
PLoS One; 2018; 13(9):e0203322. PubMed ID: 30204798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
